$SAN-FR News
Last published 7mo ago
- 7mo ago.FTSEAZN-GBROG-CHSAN-FRAstraZeneca stock jumps 4% after surprise trial win for lung disease drug where rivals have failedCNBCThe experimental drug reduced flare-ups for patients with chronic obstructive pulmonary disease, Astra said Friday.
- 2y agoUNHCVSCILLY+2FTC sues drug middlemen for allegedly inflating insulin pricesCNBCThe FTC suit targets the three biggest so-called pharmacy benefit managers, UnitedHealth Group's Optum Rx, CVS Health's Caremark and Cigna's Express Scripts.
- 2y agoCICVSUNHLLY+2Federal Trade Commission to sue drug middlemen over prices of medications including insulin, source saysCNBCUnitedHealth Group's Optum Rx, CVS Health's Caremark and Cigna's Express Scripts will reportedly be the targets of the FTC's suits.
- 2y agoGSK-GBSAN-FRPFEPharma giant GSK plunges 9% after U.S. court allows scientific testimony in Zantac lawsuitsCNBCThe Delaware State Court ruled that expert witnesses can present scientific evidence in the roughly 75,000 cases relating to the discontinued heartburn drug.
- 2y agoSNYNVAXSAN-FRPFE+3Novavax stock jumps 50% as Sanofi deal kicks off turning point for struggling vaccine makerCNBCNovavax said the deal with Sanofi allows it to remove its "going concern" warning, which it first issued last year due to doubts about staying afloat.
- 2y agoSAN-FRNVAXSNYPFE+3Novavax shares nearly double on Sanofi deal to commercialize Covid vaccine, develop combination shotsCNBCThe deal will allow Novavax to lift its "going concern" warning, which it first issued in 2023 due to having "substantial doubt" about its ability to survive.
- 2y agoSAN-FRSNYNVOLLYDiabetes drug similar to Ozempic helped slow progression of Parkinson's disease in small trialCNBCThe drug, made by Sanofi, is a GLP-1 like Novo Nordisk's blockbuster diabetes injection Ozempic and weight loss counterpart Wegovy
- 2y ago.STOXXGSGSK-GBROG-CH+4The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent Seven comparisonsCNBCOver the last 12 months, just 11 stocks made up half of the gains that powered the pan-European Stoxx 600 stock index to a record-high close on Friday.
- 2y ago.STOXXGSGSK-GBROG-CH+4The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent Seven comparisonsCNBCOver the last 12 months, just 11 stocks made up half of the gains that powered the pan-European Stoxx 600 stock index to a record-high close on Friday.
- 2y agoMRKBMYJNJMRNA+3Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug pricesCNBCThe CEOs of Merck, Johnson & Johnson and Bristol Myers Squibb will testify at the hearing on drug prices, Sen. Bernie Sanders said.
- 2y agoVKTXTERNundefinedNOVO.B-DK+8The weight loss drug market may soon get more crowded. Here are the companies trying to enter the booming spaceCNBCWall Street has been focused on Novo Nordisk, Eli Lilly and other large drugmakers hoping to join the weight loss drug market, such as Pfizer, Roche and Amgen.
- 2y agoPFEADCTJNJAMAM+4Biotech and pharma companies are betting on a promising class of cancer drugs to drive growthCNBCThe JPMorgan Healthcare Conference was likely just the beginning of another year of heightened interest and investments in ADC cancer drugs.
- 2y agoSAN-FRAZN-GBCDC expedites release of more doses of infant RSV drug from Sanofi, AstraZeneca amid shortageCNBCThe CDC's move to increase availability of Beyfortus, a monoclonal antibody from Sanofi and AstraZeneca, comes as RSV cases rise in some parts of the country.
- 3y agoSAN-FRGDRXCVSWBA+3Sanofi to offer insulin product for $35 to all Americans through GoodRxCNBCThe effort comes after Sanofi, Eli Lilly and Novo Nordisk announced sweeping insulin price cuts earlier this year.
- 3y agoPFESAN-FRNew RSV protections for infants hit cost, insurance hurdles in U.S. rolloutCNBCPfizer's maternal vaccine, Abrysvo, and Sanofi's monoclonal antibody, Beyfortus, were approved for expectant mothers and infants in the U.S. earlier this year.
- 3y agoPFESAN-FRAZN-GBCDC advisors recommend Pfizer maternal RSV vaccine to protect infantsCNBCCDC Director Mandy Cohen still needs to sign off on that recommendation before mothers can receive Pfizer's shot to protect their infants from RSV.
- 3y agoPFESAN-FRAZN-GBFDA approves Pfizer maternal RSV vaccine for infantsCNBCPfizer hopes that its respiratory syncytial virus vaccine will be available to the public by the end of October or the beginning of November.
- 3y agoNOVO.B-DKSAN-FRAZN-GBLLYUK investigates weight loss, diabetes drugs like Wegovy and Ozempic for suicide risksCNBCThe probe into potentially life-threatening side effects comes as the drugs skyrocket in popularity in the U.S. and draw heightened investor interest.
- 3y agoAZN-GBSAN-FRSanofi expects infant RSV shot to roll out before respiratory virus season this fallCNBCSanofi said it is working with a CDC panel to include Beyfortus on the childhood immunization schedule and the Vaccines for Children Program.
- 3y agoSAN-FRAZN-GBFDA approves AstraZeneca, Sanofi shot that protects infants and toddlers against RSVCNBC
- 3y agoLLYSAN-FRNOVO.B-DKUninsured Americans pay high costs for an insulin Eli Lilly vowed to price at $25, Sen. Warren saysCNBCWarren said the report shows that Congress needs to take additional steps to reduce the excessive prices of insulin from Eli Lilly, Sanofi and Novo Nordisk.
- 3y agoMRNAPFEAZN-GBNOVO.B-DK+3Moderna strikes deal to develop mRNA drugs in ChinaCNBCThe deal is the biotech company's first agreement with China after the Asian nation repeatedly refused to accept mRNA vaccines from U.S.-based manufacturers.
- 3y agoSAN-FRAZN-GBFDA advisors recommend AstraZeneca antibody to protect babies from RSVCNBCIf the Food and Drug Administration approves nirsevimab, it will be the first medical intervention available in the U.S. that can protect infants from RSV.
- 3y agoNOVO.B-DKSAN-FRLLYCVS+1Eli Lilly, Novo Nordisk and Sanofi CEOs to testify before Senate on lowering insulin pricesCNBCEli Lilly, Novo Nordisk and Sanofi control 90% of the insulin market in the U.S, where a quarter of all health care spending is on people with diabetes.
- 3y agoSAN-FRSenate legislation would cap insulin at $35 per month for people with private insuranceCNBCMore than 2 million patients with diabetes who take insulin are privately insured, according to the Health and Human Services Department.
- 3y agoSAN-FRSNYREGNSanofi, Regeneron shares pop more than 6% after data shows asthma drug Dupixent may also treat COPDCNBCSanofi and Regeneron unveiled data on their jointly developed drug for a difficult-to-treat chronic lung disorder that analysts say "exceeded expectations."
- 4y agoAADITTWOTDOC+16Stocks making the biggest moves midday: Bed Bath & Beyond, Krispy Kreme, Target and moreCNBCThese are the stocks posting the largest moves midday.
- 4y agoGSKSAN-FRHLN-GBPharma stocks crater as investors brace for billions in heartburn drug litigation chargesCNBCFor many investors and analysts, this ordeal brings back memories of the Bayer Roundup saga.
- 4y agoCAHSIXDISPFE+11Stocks making the biggest moves midday: Six Flags, Disney, Sonos and moreCNBCThese are the stocks posting the largest moves in midday trading.
- 4y agoAEO9866-HKULVR-GBFANG+9Stocks making the biggest moves midday: American Eagle Outfitters, Unilever, Nio and moreCNBCThese are the stocks posting the largest moves in midday trading.
- 4y agoYRI-CAGFI-ZACSG.N-CHULVR-GB+5Stocks making the biggest moves premarket: Yamana Gold, Credit Suisse, Unilever and moreCNBCThese are the stocks posting the largest moves before the bell.
- 4y agoSTLA-ITSPCEPANWTUP+10Stocks making the biggest moves premarket: Lowe's, Tenneco, Tupperware and othersCNBCThese are the stocks posting the largest moves before the bell.
- 4y agoBDXTMOSAN-FRROG-CHThe at-home testing industry, from Covid to cancer, may be worth over $2 billion by 2025CNBCThe emerging marketplace of consumer-initiated lab testing may be worth more than $2 billion by 2025, according to Quest Diagnostics.
- 4y agoNEESPROMRNAONON+5Cramer's lightning round: NextEra Energy is a buyCNBC"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.
- 5y agoFTHOAMATFDS+13Stocks making the biggest moves in the premarket: Ford, Thor Industries, Applied Materials and moreCNBCThe stocks making the biggest moves in premarket trading include Ford, Thor Industries, Applied Materials, and more.
- 5y agoUAATBIOSAN-FRPFE+11Stocks making the biggest moves in the premarket: Under Armour, Translate Bio, Clorox and moreCNBCThe stocks making the biggest moves in premarket trading include Under Armour, Translate Bio, Clorox, and more.
- 5y agoWMTSAN-FRLLYAMZN+2Walmart unveils low-price insulin as more patients with diabetes struggle to pay for drugCNBCThe nation's largest retailer is bringing its focus on "everyday low price" to a diabetes drug that has soared in cost and drawn scrutiny from lawmakers.
- 5y agoTDISCANFLXDIS+12Stocks making the biggest moves in the premarket: AT&T, Discovery, ViacomCBS, MicroStrategy & moreCNBCThe stocks making the biggest moves in premarket trading include AT&T, Discovery, ViacomCBS, MicroStrategy, and more.
- 5y agoTSLA.SPXAAPLMSFT+95 things to know before the stock market opens MondayCNBCU.S. stock futures were mixed ahead of an onslaught of tech earnings this week, starting with Tesla after-the-bell Monday.
- 5y agoSAN-FRCVSWBAOp-Ed: Sanofi CEO on navigating Covid one year later. Now what?CNBC
- 5y agoULTAPOSHNVAXDOCU+13Stocks making the biggest moves premarket: Ulta, Poshmark, Novavax and othersCNBCThese are the stocks posting the largest moves before the bell.
- 5y agoGSK-GBSAN-FRGSK, Sanofi begin new Covid-19 vaccine trial after setback last yearCNBCBritain's GlaxoSmithKline and France's Sanofi on Monday said they had started a new clinical trial of their protein-based Covid-19 vaccine candidate.
- 5y agoPLTRANMSTRSTZ+17Stocks making the biggest moves in the premarket: Palantir, MicroStrategy, CoreLogic & moreCNBCThe stocks making the biggest moves in premarket trading include Palantir, MicroStrategy, CoreLogic, and more.
- 5y agoBATVFCADP+17Stocks making the biggest moves in the premarket: Boeing, AT&T, VF Corp., Starbucks & moreCNBCThe stocks making the biggest moves in premarket trading include Boeing, AT&T, VF Corp., Starbucks, and more.
- 5y agoSAN-FRPFEBNTXAZN-GB+1Sanofi to produce 100 million doses of Pfizer-BioNTech vaccine, CEO saysCNBCSanofi will fill and pack millions of doses of Pfizer's Covid-19 vaccine from July in an effort to help meet the huge demand for the U.S. drugmaker's shots.
- 5y agoTWTRNCRCATMAPO+16Stocks making the biggest moves in the premarket: Twitter, Gilead Sciences, Lululemon & moreCNBCThe stocks making the biggest moves in premarket trading include Twitter, Gilead Sciences, Lululemon, and more.
- 5y agoDISQCOMAAPLNIO+13Stocks making the biggest moves in the premarket: Disney, Qualcomm, Nio, Lululemon & moreCNBCThe stocks making the biggest moves in premarket trading include Disney, Qualcomm, Nio, Lululemon, and more.
- 5y agoPFEMRNAJNJSAN-FR+3Now that two highly effective Covid vaccines are within reach, we just have to get them to 7.8 billion peopleCNBCNow comes the tricky part, distributing the vaccines — both of which require two doses given about a month apart — to billions of people across the world.
- 5y agoPFEMRNAJNJSAN-FR+3HHS Secretary Azar says the FDA will move 'as quickly as possible' to clear Moderna and Pfizer's Covid vaccinesCNBCHHS Secretary Alex Azar said Monday that the FDA will move "as quickly as possible" to issue an authorization for Covid-19 vaccines from Pfizer and Moderna.
- 6y agoPFEBNTXAZN-GBSAN-FR+4EU seals deal with Pfizer-BioNTech for supply of 300 million doses of Covid vaccineCNBCThe European Commission said it had sealed a deal with Pfizer and BioNTech for the supply of up to 300 million doses of their Covid-19 vaccine candidate.